{"id":78103,"date":"2012-08-08T03:11:40","date_gmt":"2012-08-08T03:11:40","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/bio-unveils-preliminary-program-for-the-2012-bio-convention-in-china.php"},"modified":"2024-08-17T15:56:30","modified_gmt":"2024-08-17T19:56:30","slug":"bio-unveils-preliminary-program-for-the-2012-bio-convention-in-china","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/bio-unveils-preliminary-program-for-the-2012-bio-convention-in-china.php","title":{"rendered":"BIO Unveils Preliminary Program for the 2012 BIO Convention in China"},"content":{"rendered":"<p><p>    WASHINGTON--(BUSINESS WIRE)--  <\/p>\n<p>    The Biotechnology Industry Organization (BIO) announces the    2nd annual     BIO Convention in China, a partnering and investor    conference that will bring together executives from    biotechnology, pharmaceutical companies and investment firms    from North America, Europe and Asia to meet and explore    business opportunities with China's emerging biotech sector.    The event will take place October 24-25, 2012 in Shanghai,    China.  <\/p>\n<p>    As China positions itself as a major global player in the    international biotechnology arena, it has included    biotechnology as one of the seven strategic priorities for    scientific and technological development in its 12th Five-year    Plan, said Alan Eisenberg, Executive Vice President of    Emerging Companies and Business Development at BIO. \"Through    distinguished speakers, exemplary programming, compelling    company presentations and exhibiting and networking    opportunities, BIO China allows attendees to explore the vast    business opportunities afforded by Chinas emerging biotech    sector.  <\/p>\n<p>    Dr. Michael Rosenblatt, M.D., executive vice president and    chief medical officer for Merck, will provide one of two    keynote addresses on October 25th. Directly following Dr.    Rosenblatts keynote, Peng Wang, Ph.D., Chief Scientific    Officer, Simcere will deliver his remarks. Governor Jon    Huntsman, former U.S. Ambassador to China and Governor of Utah,    will provide the third keynote address. Additional keynote    speakers will be announced at a later date.  <\/p>\n<p>    Panel sessions will highlight the latest issues and trends    related to doing business in China. Preliminary program topics    include the globalization of Chinese companies; innovation in    generics and biosimilars; comparative legal systems in  U.S.,    Europe and China; R&D trends in China; trends in cancer    research and regulatory review in China.  <\/p>\n<p>    BIO and the BIO China Advisory Committee set the event agenda    and program. Advisory Committee members include:  <\/p>\n<p>    BIO brings to China more than 15 years of experience in    organizing international conferences for the biotech industry,    including the BIO International Convention  the global event    for biotechnology. BIO is renowned for its successful business    development, partnering and investor meetings in North America,    Europe and Asia. Partnering at this conference will be powered    by BIO One-on-One Partnering, an interactive    environment to intelligently search, contact and schedule    private meetings with potential partners and investors.  <\/p>\n<p>    For more information on the BIO Convention in China, please    visit     here.  <\/p>\n<p>    About BIO  <\/p>\n<p>    BIO represents more than 1,100 biotechnology companies,    academic institutions, state biotechnology centers and related    organizations across the United States and in more than 30    other nations. BIO members are involved in the research and    development of innovative healthcare, agricultural, industrial    and environmental biotechnology products. BIO also produces the    BIO International Convention, the worlds largest gathering of    the biotechnology industry, along with industry-leading    investor and partnering meetings held around the world. BIO    produces     BIOtechNOW, an online portal and monthly newsletter    chronicling innovations transforming our world.     Subscribe to BIOtechNOW.  <\/p>\n<\/p>\n<p>Excerpt from:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/bio-unveils-preliminary-program-2012-170600869.html;_ylt=A2KJjank2CFQK30A1ZT_wgt.\" title=\"BIO Unveils Preliminary Program for the 2012 BIO Convention in China\" rel=\"noopener\">BIO Unveils Preliminary Program for the 2012 BIO Convention in China<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) announces the 2nd annual BIO Convention in China, a partnering and investor conference that will bring together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities with China's emerging biotech sector. The event will take place October 24-25, 2012 in Shanghai, China. As China positions itself as a major global player in the international biotechnology arena, it has included biotechnology as one of the seven strategic priorities for scientific and technological development in its 12th Five-year Plan, said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/bio-unveils-preliminary-program-for-the-2012-bio-convention-in-china.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-78103","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/78103"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=78103"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/78103\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=78103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=78103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=78103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}